Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?

Inclusion Criteria

• •≥1 year of a history of type 1 diabetes;
• •treatment with intensive insulin therapy with the use of an insulin pump (continuous subcutaneous insulin infusion, CSII) ≥3 months;
• •using continuous glucose monitoring system for at least 1 month;
• •HbA1c\<8%;
• •consent to participate in the study obtained from the parent and the patient (\>16 years of age).